Clariget

Main information

  • Trade name:
  • Clariget 125mg/ 5mL Granules for Suspension
  • Dosage:
  • 125mg/ 5mL
  • Pharmaceutical form:
  • Granules for Suspension
  • Units in package:
  • HDPE Plastic Bottle x 25mL, 50mL and 70mL
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Getz Pharma (Private) Limited

Documents

Localization

  • Available in:
  • Clariget 125mg/ 5mL Granules for Suspension
    Philippines
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Antibiotic
  • Therapeutic indications:
  • For treatment of pharyngitis/ tonsillitis; acute maxillary sinusitis; acute bacterial exacerbation of chronic bronchitis; community-acquired pneumonia; uncomplicated skin and skin structure infections; Helicobacter pylori and duodenal ulcer disease when used in combination with amoxicillin and lansoprazole or omeprazole; H. pylori and active duodenal ulcer when used in combination with omeprazole or ranitidine bismuth citrate; prevention of disseminated MAC disease in patients with advanced HIV infection; treatment of disseminated mycobacterial infections caused by M. avium or Mycobacterium intracellulare .

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DR-XY31313
  • Authorization date:
  • 06-12-2018
  • Last update:
  • 15-01-2018

Summary of Product characteristics: dosage, interactions, side effects

Each reconstitued 5mL contains: